Effectiveness of intensive stand-alone smoking cessation interventions for individuals with diabetes: A systematic review and intervention component analysis

Joseph Grech, Ian J Norman, Roberta Sammut, Joseph Grech, Ian J Norman, Roberta Sammut

Abstract

Introduction: Tobacco smoking poses a significant threat to the health of individuals living with diabetes. Intensive stand-alone smoking cessation interventions, such as multiple or long (>20 minutes) behavioral support sessions focused solely on smoking cessation, with or without the use of pharmacotherapy, increase abstinence when compared to brief advice or usual care in the general population. However, there is limited evidence so far for recommending the use of such interventions amongst individuals with diabetes. This study aimed to assess the effectiveness of intensive stand-alone smoking cessation interventions for individuals living with diabetes and to identify their critical features.

Methods: A systematic review design with the addition of a pragmatic intervention component analysis using narrative methods was adopted. The key terms 'diabetes mellitus' and 'smoking cessation' and their synonyms were searched in 15 databases in May 2022. Randomized controlled trials which assessed the effectiveness of intensive stand-alone smoking cessation interventions by comparing them to controls, specifically amongst individuals with diabetes, were included.

Results: A total of 15 articles met the inclusion criteria. Generally, the identified studies reported on the delivery of a multi-component behavioral support smoking cessation intervention for individuals with type I and type II diabetes, providing biochemically verified smoking abstinence rates at follow-up at six months. The overall risk-of-bias of most studies was judged to be of some concern. Despite observing inconsistent findings across the identified studies, interventions consisting of three to four sessions, lasting more than 20 min each, were found to be more likely to be associated with smoking cessation success. The additional use of visual aids depicting diabetes-related complications may also be useful.

Conclusions: This review provides evidence-based smoking cessation recommendations for use by individuals with diabetes. Nonetheless, given that the findings of some studies were found to be possibly at risk-of-bias, further research to establish the validity of the provided recommendations is suggested.

Keywords: diabetes complications; diabetes mellitus; intervention component analysis; smoking cessation agents; tobacco use disorder.

Conflict of interest statement

The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.

© 2023 Grech J. et al.

Figures

Figure 1
Figure 1
PRISMA flow diagram
Figure 2
Figure 2
Summary of risk-of-bias assessments performed using the RoB 2 for randomized parallel-group trials
Figure 3
Figure 3
Summary of risk-of-bias assessment performed using the RoB 2 for cluster-randomized trials

References

    1. Boyko EJ, Magliano DJ, Karuranga S, et al. IDF Diabetes Atlas. 10th ed. International Diabetes Federation; 2021. Accessed March 16, 2023. .
    1. Drope J, Schluger NW, Zachary C, et al. The Tobacco Atlas. 6th ed. American Cancer Society and Vital Strategies; 2018. Accessed March 16,2023. .
    1. World Health Organization . WHO report on the global tobacco epidemic 2021: addressing new and emerging products. World Health Organization; 2021. Accessed March 16, 2023. .
    1. Qin R, Chen T, Lou Q, Yu D. Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies. Int J Cardiol. 2013;167(2):342–350. doi: 10.1016/j.ijcard.2011.12.100.
    1. Campagna D, Alamo A, Di Pino A, et al. Smoking and diabetes: dangerous liaisons and confusing relationships. Diabetol Metab Syndr. 2019;11:85. doi: 10.1186/s13098-019-0482-2.
    1. Liao D, Ma L, Liu J, Fu P. Cigarette smoking as a risk factor for diabetic nephropathy: a systematic review and meta-analysis of prospective cohort studies. PLoS One. 2019;14(2):e0210213. doi: 10.1371/journal.pone.0210213.
    1. Kar D, Gillies C, Zaccardi F, et al. Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2016;15(1):158. doi: 10.1186/s12933-016-0475-5.
    1. Barengo NC, Teuschl Y, Moltchanov V, Laatikainen T, Jousilahti P, Tuomilehto J. Coronary heart disease incidence and mortality, and all-cause mortality among diabetic and non-diabetic people according to their smoking behavior in Finland. Tob Induc Dis. 2017;15(February):12. doi: 10.1186/s12971-017-0113-3.
    1. Hartmann-Boyce J, Livingstone-Banks J, Ordóñez-Mena JM, et al. Behavioural interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2021;1:CD013229. doi: 10.1002/14651858.CD013229.pub2.
    1. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017;3(3):CD001292. doi: 10.1002/14651858.CD001292.pub3.
    1. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:CD008286. doi: 10.1002/14651858.CD008286.pub3.
    1. Martín Cantera C, Puigdomènech E, Ballvé JL, et al. Effectiveness of multicomponent interventions in primary healthcare settings to promote continuous smoking cessation in adults: a systematic review. BMJ Open. 2015;5(10):e008807. doi: 10.1136/bmjopen-2015-008807.
    1. Nagrebetsky A, Brettell R, Roberts N, Farmer A. Smoking cessation in adults with diabetes: a systematic review and meta-analysis of data from randomised controlled trials. BMJ Open. 2014;4(3):e004107. doi: 10.1136/bmjopen-2013-004107.
    1. Zhan E, Song H, Liu W. Meta analysis of influence of psychological interventions for smoking cessation effect in diabetic patients. In Chinese. Chinese Nurs Res. 2016;30(9A):3096–3101. doi: 10.3969/j.issn.1009-6493.2016.25.008.
    1. Grech J, Norman IJ, Sammut R. Helping smokers with diabetes quit: a scoping review of the interventions utilised, and the challenges and barriers to smoking cessation. Prim Care Diabetes. 2023;17(2):119–128. doi: 10.1016/j.pcd.2023.01.005.
    1. Aromataris E, Riitano D. Constructing a search strategy and searching for evidence. A guide to the literature search for a systematic review. Am J Nurs. 2014;114(5):49–56. doi: 10.1097/01.NAJ.0000446779.99522.f6.
    1. Sutcliffe K, Thomas J, Stokes G, Hinds K, Bangpan M. Intervention Component Analysis (ICA): a pragmatic approach for identifying the critical features of complex interventions. Syst Rev. 2015;4:140. doi: 10.1186/s13643-015-0126-z.
    1. McKenzie JE, Brennan SE. Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JPT, Thomas J, Chandler J, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3. Cochrane; Updated February 2022. Accessed March 16, 2023. .
    1. Sterne JAC, Savović J, Page MJ, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:1–8. doi: 10.1136/bmj.l4898.
    1. Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3. Cochrane; Updated February 2022. Accessed March 16, 2023. .
    1. McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55–61. doi: 10.1002/jrsm.1411.
    1. Fowler PM, Hoskins PL, McGill M, Dutton SP, Yue DK, Turtle JR. Anti-smoking programme for diabetic patients: the agony and the ecstasy. Diabet Med. 1989;6(8):698–702. doi: 10.1111/j.1464-5491.1989.tb01260.x.
    1. Mini GK, Nichter M, Nair RR, Thankappan KR. Confirmation of self-reported non-smoking status by salivary cotinine among diabetes patients in Kerala, India. Clin Epidemiol Glob Heal. 2015;3(1):44–46. doi: 10.1016/j.cegh.2014.05.003.
    1. Nichter M, Mini GK, Thankappan KR. Low-level smoking among diabetes patients in India: a smoking cessation challenge. Clin Epidemiol Glob Heal. 2018;6(4):176–180. doi: 10.1016/j.cegh.2017.11.005.
    1. Thankappan KR, Mini GK, Hariharan M, Vijayakumar G, Sarma PS, Nichter M. Smoking cessation among diabetic patients in Kerala, India: 1-year follow-up results from a pilot randomized controlled trial. Diabetes Care. 2014;37(12):e256–e257. doi: 10.2337/dc14-1863.
    1. Cullum N, Dumville J. Systematic reviews of the effects of interventions. In: Richards DA, Hallberg IR, editors. Complex interventions in health: an overview of research methods. Routledge; 2015. pp. 57–65.
    1. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71. Published 2021 Mar 29.
    1. Lam TH, Li WH, Wang MP, et al. A brief, tailored smoking cessation intervention for smokers with diabetes mellitus in Hong Kong. Hong Kong Med J. 2017;23(3) Suppl 2:10–11.
    1. Thankappan KR, Mini GK, Daivadanam M, Vijayakumar G, Sarma PS, Nichter M. Feasibility of disease centered smoking cessation among diabetes patients. Respir Med. 2013;107(suppl 1):S16. doi: 10.1016/s0954-6111(13)70057-x.
    1. Li WH, Wang MP, Lam TH, et al. Brief intervention to promote smoking cessation and improve glycemic control in smokers with type 2 diabetes: a randomized controlled trial. Sci Rep. 2017;7:45902. doi: 10.1038/srep45902.
    1. Thankappan KR, Mini GK, Daivadanam M, Vijayakumar G, Sarma PS, Nichter M. Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India. BMC Public Health. 2013;13:47. doi: 10.1186/1471-2458-13-47.
    1. Pérez-Tortosa S, Roig L, Manresa JM, et al. Continued smoking abstinence in diabetic patients in primary care: a cluster randomized controlled multicenter study. Diabetes Res Clin Pract. 2015;107(1):94–103. doi: 10.1016/j.diabres.2014.09.009.
    1. Albaroodi K, Syed Sulaiman SA, Awaisu A, Shafie A. Impact of brief smoking cessation intervention on abstinence rate and glycaemic control in patients with diabetes mellitus: a randomised controlled trial. Res Sq. Preprint posted online January 28, 2021.
    1. Ardron M, MacFarlane IA, Robinson C, van Heyningen C, Calverley PM. Anti-smoking advice for young diabetic smokers: is it a waste of breath? Diabet Med. 1988;5(7):667–670. doi: 10.1111/j.1464-5491.1988.tb01077.x.
    1. Canga N, De Irala J, Vara E, Duaso MJ, Ferrer A, Martínez-González MA. Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diabetes Care. 2000;23(10):1455–1460. doi: 10.2337/diacare.23.10.1455.
    1. Sawicki PT, Didjurgeit U, Mühlhauser I, Berger M. Behaviour therapy versus doctor's anti-smoking advice in diabetic patients. J Intern Med. 1993;234(4):407–409. doi: 10.1111/j.1365-2796.1993.tb00763.x.
    1. Hokanson JM, Anderson RL, Hennrikus DJ, Lando HA, Kendall DM. Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco. Diabetes Educ. 2006;32(4):562–570. doi: 10.1177/0145721706289914.
    1. Ng N, Nichter M, Padmawati RS, Prabandari YS, Muramoto M, Nichter M. Bringing smoking cessation to diabetes clinics in Indonesia. Chronic Illn. 2010;6(2):125–135. doi: 10.1177/1742395310364253.
    1. Prochaska JO, DiClemente CC, Velicer WF, Ginpil S, Norcross JC. Predicting change in smoking status for self-changers. Addict Behav. 1985;10(4):395–406. doi: 10.1016/0306-4603(85)90036-x.
    1. Noar SM, Hall MG, Francis DB, Ribisl KM, Pepper JK, Brewer NT. Pictorial cigarette pack warnings: a meta-analysis of experimental studies. Tob Control. 2016;25(3):341–354. doi: 10.1136/tobaccocontrol-2014-051978.
    1. Livingstone-Banks J, Ordóñez-Mena JM, Hartmann-Boyce J. Print-based self-help interventions for smoking cessation. Cochrane Database Syst Rev. 2019;(1):1–112. doi: 10.1002/14651858.CD001118.pub4.
    1. Lindson N, Thompson TP, Ferrey A, Lambert JD, Aveyard P. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2019;(7):CD006936. doi: 10.1002/14651858.CD006936.pub4.
    1. Roig L, Perez S, Prieto G, et al. Cluster randomized trial in smoking cessation with intensive advice in diabetic patients in primary care. ITADI Study. BMC Public Health. 2010;10:58. doi: 10.1186/1471-2458-10-58.
    1. Cahill K, Lancaster T, Green N. Stage-based interventions for smoking cessation. Cochrane Database Syst Rev. 2010;(11):CD004492. doi: 10.1002/14651858.CD004492.pub4.
    1. Etter JF, Sutton S. Assessing 'stage of change' in current and former smokers. Addiction. 2002;97(9):1171–1182. doi: 10.1046/j.1360-0443.2002.00198.x.
    1. West R. Time for a change: putting the Transtheoretical (stages of change) Model to rest. Addiction. 2005;100:1036–1039. doi: 10.1111/j.1360-0443.2005.01139.x.
    1. European Network for Smoking and Tobacco Prevention . Guidelines for treating tobacco dependence. 2020. European Netwwork for Smoking and Tobacco Prevention; 2020. Accessed March 16, 2023. .
    1. Lotrean LM. Smoking cessation in patients with diabetes. In: Behrakis P, Vardavas C, Papadakis S, editors. Tobacco cessation guidelines for high-risk populations. 2017. pp. 150–191. Accessed March 16, 2023. .
    1. Richards DA. The critical importance of patient and public involvement for research into complex interventions. In: Richards DA, Hallberg IR, editors. Complex interventions in health: an overview of research methods. Routledge; 2015. pp. 46–50.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe